GlassScriptPhysician profile
Bryan W Mcgwier
NPI 1992758874
$1,406.81
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.88 · 2020: $27.32 · 2021: $104 · 2022: $795 · 2023: $308 · 2024: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $459.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $459.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $261.14 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $250.58 | 2021-2022 | |
| Pfizer INC. | $126.81 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $115.04 | 2022-2024 | Verquvo |
| Cvrx, INC. | $111.86 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $98.19 | 2022-2023 | Lifevest |
| Amgen INC. | $91.56 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $72.09 | 2022-2023 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $58.28 | 2021-2024 | Farxiga |
| Irhythm Technologies, INC. | $39.10 | 2022-2023 | Zio Xt Patch |
| Actelion Pharmaceuticals US, INC. | $38.35 | 2022-2023 | Opsumit |
| Abbott Laboratories | $34.43 | 2021-2024 | Supera |
| E.R. Squibb & Sons, L.L.C. | $28.75 | 2022-2023 | Camzyos |
| Kiniksa Pharmaceuticals International, Plc | $23.79 | 2024 | Arcalyst |
| Medtronic, INC. | $22.66 | 2024 | Mosaic |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $20.89 | 2023 | |
| Ethicon US, LLC | $13.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Mcgwier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.